FindTrial
Sign In

/

/ - /

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2015-000142-29-FR
Enrollment
Unknown
Registered
2015-06-03
Start date
2015-04-13
Completion date
Unknown
Last updated
2016-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Kétamine Product Name: KETAMINE Pharmaceutical Form: Injection Pharmaceutical form of the placebo: Injection Route of administration of the placebo: Intravenous drip use (Noncurrent) Trad

Sponsors

CHU CLERMONT-FERRAND
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: / Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 22 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 22

Exclusion criteria

Exclusion criteria: /

Design outcomes

Primary

MeasureTime frame
Main Objective: /;Secondary Objective: /;Primary end point(s): /;Timepoint(s) of evaluation of this end point: /—

Secondary

MeasureTime frame
Secondary end point(s): /;Timepoint(s) of evaluation of this end point: /—

Countries

France

Contacts

Public ContactPatrick LACARIN

CHU CLERMONT-FERRAND

0033473751195

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026